Holen Sie sich die Stockscreener-App
4.9301
1.79%
-0.0999
Schlusskurs vom Vortag:
$5.03
Offen:
$5.09
24-Stunden-Volumen:
749.38K
Relative Volume:
1.62
Marktkapitalisierung:
$1.57B
Einnahmen:
$391.87M
Nettoeinkommen (Verlust:
$-441.45M
KGV:
-2.6649
EPS:
-1.85
Netto-Cashflow:
$-301.21M
1W Leistung:
-37.23%
1M Leistung:
-40.62%
6M Leistung:
-39.90%
1J Leistung:
-61.76%
1-Tages-Spanne:
$4.85
$5.10
1-Wochen-Bereich:
$4.81
$8.01
52-Wochen-Spanne:
$4.81
$13.70
Alvotech Stock (ALVO) Company Profile
Vergleichen Sie ALVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
4.94 | 1.57B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
126.85 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.62 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.335 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.45 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.13 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-02-14 | Eingeleitet | UBS | Buy |
| 2024-01-29 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-07 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Herabstufung | Citigroup | Buy → Sell |
| 2022-07-26 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Alvotech Aktie (ALVO) Neueste Nachrichten
Alvotech SA Securities Lawsuit Investigation - Claim Depot
Alvotech price target lowered to $10 from $28 at Northland - TipRanks
Deutsche Bank Downgrades Alvotech to Hold From Buy, Cuts Price Target to $8 From $14 - MarketScreener
Alvotech plant issues foil another FDA review, this time for Teva-partnered Simponi biosimilar - Fierce Pharma
This Kimberly-Clark Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - inkl
Alvotech (NASDAQ: ALVO) sets 10:45 am EDT fireside chat on Sept 10 with webcast - Stock Titan
Deutsche Bank downgrades Alvotech stock to Hold on manufacturing issues - Investing.com
Deutsche Bank downgrades Alvotech stock to Hold on manufacturing issues By Investing.com - Investing.com Nigeria
Risk adjusted return profile for Alvotech analyzed2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
FDA Rejects Alvotech’s Biosimilar AVT05 for Simponi Citing Manufacturing Deficiencies - geneonline.com
Is Alvotech stock a smart buy before Fed meetingJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Will Alvotech Equity Warrant stock deliver shareholder valueWeekly Risk Summary & Short-Term Swing Trade Alerts - newser.com
Alvotech faces FDA setback for its Simponi biosimilar AVT05 - Pharmaceutical Technology
Trend analysis for Alvotech this weekMarket Risk Summary & Community Consensus Picks - newser.com
How Alvotech (Z45) stock trades under stagflationJuly 2025 Trade Ideas & Daily Market Momentum Tracking - newser.com
A Look at Alvotech (NasdaqGM:ALVO) Valuation Following FDA Setback and 2025 Outlook Revision - simplywall.st
A Fresh Look at Alvotech (NasdaqGM:ALVO) Valuation Following Recent Share Price Decline - Yahoo Finance
ALVO Investor ALERT: Block & Leviton Investigating Alvotech for Securities Fraud; Investors ... - Bluefield Daily Telegraph
ALVO Investor ALERT: Block & Leviton Investigating Alvotech - GlobeNewswire
Gold Edges Higher; ISM Manufacturing PMI Falls In October - Benzinga
Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance (ALVO) - Seeking Alpha
Alvotech Shares Plunge 33% After FDA Flags Issues - Benzinga
Alvotech fell heavily on the Stockholm Stock Exchange, and the OMXS30 index fell 0.4 percent. - MarketScreener
Alvotech drops after US FDA declines to approve arthritis drug - TradingView
Alvotech stock hits 52-week low at 5.82 USD - Investing.com
What technical patterns form on Alvotech (Z45) stock chartsJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
What analysts say about Alvotech Z45 stockSwing Trading Watchlist & Low Investment Wealth Tips - earlytimes.in
Alvotech Shares Slide After FDA Requests Further Action on Simponi Biosimilar - MSN
Applying Wyckoff theory to Alvotech Equity Warrant stockMarket Activity Report & High Accuracy Investment Signals - newser.com
Will Alvotech (Z45) stock rise with strong economy2025 Top Gainers & Capital Efficient Trade Techniques - newser.com
Is Alvotech stock positioned for digital transformationJuly 2025 Breakouts & Smart Money Movement Tracker - newser.com
How Alvotech stock performs in high volatility markets2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
Alvotech stock falls after FDA issues complete response letter - Investing.com
Alvotech stock falls after FDA issues complete response letter By Investing.com - Investing.com Nigeria
Alvotech Hit By FDA Setback On Key Arthritis Drug - Finimize
Alvotech Equity Warrant stock daily chart insights2025 Fundamental Recap & Technical Buy Zone Confirmations - newser.com
Alvotech falls heavily on the Stockholm Stock Exchange, OMXS30 index rises 0.2 percent - MarketScreener
Alvotech Shares Plunge As FDA Declines To Approve AVT05, A Biosimilar To Simponi - Nasdaq
Alvotech Faces FDA Setback for AVT05 Biosimilar Application - TipRanks
What candlestick patterns are forming on AlvotechTrade Risk Summary & Stepwise Entry and Exit Trade Signals - newser.com
Alvotech stock slides as FDA issues CRL for AVT05, company cuts EBITDA outlook - MSN
What the charts say about Alvotech Equity Warrant today2025 Retail Activity & Real-Time Volume Triggers - newser.com
Alvotech stock slides as FDA issues CRL for AVT05, company cuts EBITDA outlook (ALVO:NASDAQ) - Seeking Alpha
Applying chart zones and confluence areas to AlvotechWatch List & Stepwise Trade Signal Guides - newser.com
Bittersweet Simponi Verdict For Alvotech As US FDA Knocks Back Golimumab Filing - Citeline News & Insights
Why Alvotech Shares Are Facing Turbulence - TipRanks
Will Alvotech stock benefit from AI adoptionQuarterly Risk Review & Accurate Entry and Exit Point Alerts - newser.com
Has Alvotech formed a bullish divergence2025 Performance Recap & Comprehensive Market Scan Insights - newser.com
Alvotech (ALVO) Stock: Slips Amid FDA Setback on Simponi Biosimilar AVT05 - parameter.io
Using RSI to spot recovery in Alvotech Equity Warrant2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Finanzdaten der Alvotech-Aktie (ALVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):